GSK Pharmaceuticals' EBITDA in India FY 2015-2022

Published by
Sanyukta Kanwal,
Jul 21, 2022
In fiscal year 2022, GlaxoSmithKline Pharmaceuticals Limited in India had 7.56 billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 5.98 billion rupees worth EBITDA.

EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2022 (in billion Indian rupees)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2022

Region

India

Survey time period

FY 2015 to FY 2022

Supplementary notes

One Indian rupee is equal to 0.012 euros and 0.012 U.S. dollars (as of July 2022).

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Market overview

6

GSK India - key figures

6

Product portfolio

3

Main competitiors

4

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu